Overview
Leucine:Isoleucine:Valine for muscle.
- Dietary protein from animal sources (meat, fish, eggs, dairy) and plant sources (soy, legumes, grains)
- Free-form amino acid powders and capsules
- Targeted pre-workout, recovery, or sleep formulations
- Free-form crystalline powder
- Capsules or tablets
- Pre-mixed recovery or hydration beverages
- Time-release formulations
Mechanism of action
Leucine-rich blend stimulates mTOR.
- · Leucine-rich blend stimulates mTOR
Effects on the body
Organ system effects
BCAA 2:1:1 influences muscle protein synthesis, neuromuscular output, or recovery from exercise.
Evidence-based benefits
Reduces DOMS
Moderate evidencePotential side effects
- · Well tolerated
Drug interactions
Supplement interactions
- Creatine monohydrateFoundational support for strength, power, and lean mass.
- Whey or EAAsProvides amino acid substrate for muscle protein synthesis.
No specific avoidances listed.
Dosing & bioavailability
Where to buy
Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.
Third-party testedIndependently verified BCAA 2:1:1 — look for USP, NSF, or Informed Sport seals on the label for purity and dose accuracy.BCAA 2:1:1 third party tested NSF
CapsulesPre-measured BCAA 2:1:1 capsules — easiest for travel and consistent daily dosing without scoops or scales.BCAA 2:1:1 capsules
PowderBulk unflavored BCAA 2:1:1 powder — best cost-per-gram and flexible dosing for stacking or mixing into drinks.BCAA 2:1:1 powder unflavored
Best sellersMost-purchased BCAA 2:1:1 products on Amazon — a quick way to see what's reviewed widely before you commit.BCAA 2:1:1 best sellerScientific evidence8Show studiesHide studies
BCAA for DOMS
Howatson G, et al.
12 trained men
Reduced muscle soreness.
PubMed: BCAA 2:1:1 — Reduces DOMS
Live PubMed search
Live results for "BCAA 2:1:1 Reduces DOMS" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching BCAA 2:1:1 and "Reduces DOMS". Filter by RCT, meta-analysis, or year on the results page.
PubMed: BCAA 2:1:1 — randomized controlled trial
Live PubMed search
Live results for "BCAA 2:1:1 randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching BCAA 2:1:1 and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
PubMed: BCAA 2:1:1 — meta-analysis
Live PubMed search
Live results for "BCAA 2:1:1 meta-analysis" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching BCAA 2:1:1 and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
PubMed: BCAA 2:1:1 — pharmacokinetics
Live PubMed search
Live results for "BCAA 2:1:1 pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching BCAA 2:1:1 and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.
PubMed: BCAA 2:1:1 — safety adverse events
Live PubMed search
Live results for "BCAA 2:1:1 safety adverse events" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching BCAA 2:1:1 and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.
PubMed: BCAA 2:1:1 — dose response
Live PubMed search
Live results for "BCAA 2:1:1 dose response" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching BCAA 2:1:1 and "dose response". Filter by RCT, meta-analysis, or year on the results page.
Google Scholar: BCAA 2:1:1 — clinical evidence
Live Scholar search
Cross-database citation index for BCAA 2:1:1 as it relates to "clinical evidence".
Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.